March 15, 2021
Kyowa Kirin said on March 12 that it has submitted an application seeking an additional indication for G-Lasta (pegfilgrastim), a sustained-release G-CSF preparation, for the mobilization of hematopoietic stem cells into peripheral blood in allogeneic blood stem cell transplantation. The...read more